Northstar Asset Management Inc. increased its position in shares of Xylem Inc. (NYSE:XYL – Free Report) by 0.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,680 shares of the industrial products company’s stock after acquiring an additional 415 shares during the period. Xylem makes up about 2.8% of Northstar Asset Management Inc.’s investment portfolio, making the stock its 14th largest position. Northstar Asset Management Inc.’s holdings in Xylem were worth $10,307,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. boosted its position in shares of Xylem by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock valued at $3,465,122,000 after purchasing an additional 362,127 shares during the period. Swedbank AB boosted its position in shares of Xylem by 13.9% in the 2nd quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock valued at $564,906,000 after purchasing an additional 531,890 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Xylem by 7.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company’s stock valued at $480,767,000 after purchasing an additional 274,123 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of Xylem by 689.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock valued at $443,074,000 after purchasing an additional 3,239,203 shares during the period. Finally, Northern Trust Corp boosted its position in shares of Xylem by 2.9% in the 1st quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company’s stock valued at $401,743,000 after purchasing an additional 94,560 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.
Xylem Stock Up 0.4%
XYL opened at $148.31 on Friday. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $151.16. The business has a 50-day moving average of $143.79 and a 200-day moving average of $132.56. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. The company has a market capitalization of $36.10 billion, a PE ratio of 38.52, a price-to-earnings-growth ratio of 2.52 and a beta of 1.13.
Xylem Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem’s dividend payout ratio (DPR) is presently 41.56%.
Insider Buying and Selling at Xylem
In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the transaction, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. This trade represents a 25.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.27% of the company’s stock.
Analyst Upgrades and Downgrades
XYL has been the subject of a number of recent analyst reports. Zacks Research upgraded Xylem from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 22nd. Stifel Nicolaus increased their price target on Xylem from $162.00 to $175.00 and gave the company a “buy” rating in a research report on Friday, August 1st. Wall Street Zen upgraded Xylem from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. Cowen restated a “hold” rating on shares of Xylem in a research report on Tuesday, August 26th. Finally, Mizuho raised their price objective on Xylem from $125.00 to $140.00 and gave the stock a “neutral” rating in a research report on Friday, September 12th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $154.67.
View Our Latest Research Report on XYL
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories
- Five stocks we like better than Xylem
- 5 Top Rated Dividend Stocks to Consider
- Time to Take Notice: PEGA’s GenAI Blueprint Delivers Huge Q3 Beat
- Want to Profit on the Downtrend? Downtrends, Explained.
- MarketBeat Week in Review – 10/20 – 10/24
- What Makes a Stock a Good Dividend Stock?
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
